Efficacy and Safety of Ureteroscopic Lithotripsy (Including Flexible Ureteroscopy) Without Indwelling Urinary Catheter

Efficacy and Safety of Ureteroscopic Lithotripsy (Including Flexible Ureteroscopy) Without Indwelling Urinary Catheter: a Multicenter, Randomized, Controlled Study

A prospective, multicenter, randomized, controlled clinical trial was conducted to compare the efficacy and safety of non-indwelling catheter and indwelling catheter in relieving postoperative catheter-related complications after ureteroscopic lithotripsy. By comparing the pain score and urination urgency score (PPIUS) of patients after ureteroscopic lithotripsy (including flexible ureteroscopy) lithotripsy to provide a reliable scientific basis for indwelling catheter after ureteroscopic lithotripsy.

Study Overview

Study Type

Interventional

Enrollment (Actual)

180

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Shanghai Municipality
      • Shanghai, Shanghai Municipality, China, 200080
        • Shanghai General Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients with upper urinary tract calculi undergoing rigid ureteroscopic and soft ureteroscopic lithotripsy;
  • Normal renal function;
  • Aged between 18 and 70 years old
  • Complete the operation under general anesthesia

Exclusion Criteria:

  • Solitary kidney;
  • Previous history of renal transplantation or urinary diversion;
  • Congenital malformation of urinary system;
  • Abnormal coagulation mechanism due to blood system diseases, liver diseases, etc.
  • Severe heart or lung disease, Malignant tumor and immunodeficiency state
  • Urethral stricture
  • Neurogenic bladder
  • Operation under epidural anesthesia or spinal anesthesia
  • Large amount of bleeding during operation should be observed by indwelling catheter to observe urine color
  • High risk factors such as large amount of pus fur should be observed during operation.
  • Urethral injury during operation leads to false passage
  • Operation time is more than 90 minutes. Higher risk of bleeding or infection

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Group 1: Ureteroscopy (including flexible endoscope) lithotripsy with indwelling urinary catheter
Ureteroscopy (including flexible endoscope) lithotripsy with indwelling urinary catheter
Ureteroscopy (including flexible endoscope) lithotripsy with indwelling urinary catheter
Experimental: Group 2: Ureteroscopy (including flexible endoscope) lithotripsy without indwelling urinary catheter
Ureteroscopy (including flexible endoscope) lithotripsy without indwelling urinary catheter
Ureteroscopy (including flexible endoscope) lithotripsy without indwelling urinary catheter

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain score
Time Frame: 4 hours after surgery and 2 hours after catheter removal (same time points for non-indwelling catheters)
pain scoring will be measured by VAS scale. There are 10 scales, with "0" and "10" at both ends. 0 indicates no pain and 10 represents the most severe pain that is unbearable.
4 hours after surgery and 2 hours after catheter removal (same time points for non-indwelling catheters)
Urinary urgency score
Time Frame: 4 hours after surgery and 2 hours after catheter removal (same time points for non-indwelling catheters)

urinary urgency score will be measured by PPIUS scale. 0 No urgency

  1. Mild urgency
  2. Moderate urgency
  3. Severe urgency
  4. Urge incontinence
4 hours after surgery and 2 hours after catheter removal (same time points for non-indwelling catheters)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Painful Memory
Time Frame: 1 month after surgery
Painful memory will be measured by SUDS scale. 100: Unbearably upset to the point that you cannot function and may be on the verge of a breakdown 90: Extremely anxious and desperate; helpless and unable to handle it 80: Worried and panicky; losing focus and feeling anxious in your body 70: Discomfort dominates your thoughts and you struggle to function normally 60: Moderate to strong levels of discomfort 50: Upset and uncomfortable; still functional 40: Mild to moderate anxiety and worry 30: Worried or upset; still able to function 20: A little bit sad or distressed 10: No distress; alert and focused 0: Peaceful and complete calm
1 month after surgery
Operation time
Time Frame: The end of operation
Operation time
The end of operation
blood routine
Time Frame: Before surgery and 4 hours after surgery
To calculate the change of haemoglobin
Before surgery and 4 hours after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2024

Primary Completion (Actual)

June 30, 2025

Study Completion (Actual)

June 30, 2025

Study Registration Dates

First Submitted

June 3, 2024

First Submitted That Met QC Criteria

June 9, 2024

First Posted (Actual)

June 13, 2024

Study Record Updates

Last Update Posted (Actual)

November 19, 2025

Last Update Submitted That Met QC Criteria

November 17, 2025

Last Verified

November 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

After the trial is completed, it is shared on the network platform: China Clinical trial Registration Center; website: http://www.chictr.org.cn

IPD Sharing Time Frame

After the trial is completed,

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • ICF
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Urolithiasis

Clinical Trials on Ureteroscopy (including flexible endoscope) lithotripsy with indwelling urinary catheter

Subscribe